Prostate Cancer - Results from #20740

Estimating age and ethnic variation in the histological prevalence of prostate cancer to inform the impact of screening policies - Abstract May 27, 2014

Patterns of androgen deprivation therapies among men diagnosed with localised prostate cancer: A population-based study - Abstract May 27, 2014

Longitudinal trends in prostate cancer incidence, mortality, and survival of patients from two Shanghai city districts: A retrospective population-based cohort study, 2000-2009 - Abstract May 27, 2014

Influence of body mass index and periprostatic fat on rectal dosimetry in permanent seed prostate brachytherapy - Abstract May 27, 2014

The influence of age and comorbidity on the benefit of adding androgen deprivation to dose-escalated radiation in men with intermediate-risk prostate cancer - Abstract May 27, 2014

Multiparametric magnetic resonance imaging of the prostate aids to detect lesion progression - Abstract May 27, 2014

Humoral response to a viral glycan correlates with survival on PROSTVAC-VF - Abstract May 26, 2014

Comparative effectiveness of robot-assisted and open radical prostatectomy in the postdissemination era - Abstract May 26, 2014

Bone abnormal signal incidentally found in pre-biopsy diffusion-weighted MRI for suspected prostate cancer: What does it reflect? - Abstract May 26, 2014

Diagnostic performance and safety of a three-dimensional 14-core systematic biopsy method - Abstract May 26, 2014

Laparoscopic versus robotic-assisted radical prostatectomy: An Australian single-surgeon series - Abstract May 24, 2014

A 30-year experience of Millin's retropubic prostatectomy: Has this classic operation derived by a President of the College in Ireland stood the test of time? - Abstract May 24, 2014

Determinants of vitamin D levels in men receiving androgen deprivation therapy for prostate cancer - Abstract May 24, 2014

Clinical value of extended pelvic lymph node dissection in patients subjected to radical prostatectomy - Abstract May 24, 2014

Does statin or ASA affect survival when prostate cancer is treated with external beam radiation therapy? - Abstract May 24, 2014

Prospective study on the relationship between clinical efficacy of secondary hormone therapy with flutamide and neuroendocrine differentiation in patients with relapsed prostate cancer after first line hormone therapy - Abstract May 24, 2014

Angiosarcoma of the prostate: A more frequent finding in the future owing to radiotherapy? A literature review with treatment implications based on a case report - Abstract May 24, 2014

Outcomes of men with an elevated PSA as their sole preoperative intermediate or high risk feature - Abstract May 23, 2014

When is prostate cancer really cancer? - Abstract May 23, 2014

Increasing use of dose-escalated external beam radiation therapy for men with nonmetastatic prostate cancer - Abstract May 23, 2014

Page 1038 of 1447